Vistin Pharma ASA is a Norway-based holding company operating in the pharmaceuticals sector through its subsidiary Vistin Pharma AS. It specializes in the production and global supply of metformin HCl active pharmaceutical ingredients (APIs) and direct compressive granulates, essential for medications treating type 2 diabetes. As a dedicated European producer, Vistin Pharma ASA emphasizes high-quality manufacturing, environmental sustainability, social responsibility, and ethical practices to meet the demands of international pharmaceutical companies. Founded in 1969 and headquartered in Oslo, the company serves diverse markets including Europe, Africa, Asia, and the Americas, with sales primarily concentrated in Europe. Employing around 73 people, it maintains a focused operation in generic pharmaceuticals, positioning itself as a reliable supplier in the growing global diabetes treatment market. Key leadership includes CEO Magnus Tolleshaug and Chairman Øyvin Anders Brøymer, supported by a board of experienced directors. Vistin Pharma ASA plays a vital role in ensuring stable supply chains for critical diabetes therapies.